News

Categories
Sign up
Featured Posts
Archive
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

Newsletter - Issue no. 3

Dear Colleagues and Friends, I am thrilled to share with you our newest developments achieved in the past months - whether it comes to new collaborations, approvals, research or operational developments, Alpha Tau is rapidly progressing! In the last several weeks, we have seen tremendous interest from the medical community in our Alpha DaRT treatment. Committees at the most prestigious industry meetings, including the American Societies for Radiation Oncology (ASTRO) and Brachytherapy (ABS), selected our scientists to present their latest results from our preclinical and clinical studies. I am even more excited to report that Prof. Keisari, the co-inventor of the Alpha DaRT technology, won t

Alpha Tau

Looking for clinical trials?

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon